Amy L Barfield, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Hospital Blvd Ste 130, Roswell, GA 30076 Phone: 770-740-1753 Fax: 770-740-8503 |
Ms. Suzanne Jeannette Ferree, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11660 Alpharetta Hwy Ste 290, Roswell, GA 30076 Phone: 404-446-3600 Fax: 404-446-3609 |
Dr. Kumuda Ranjan, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 9420 Willeo Rd, Roswell, GA 30075 Phone: 404-439-9851 Fax: 404-994-5765 |
Dr. Deedee T Diep, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 Hospital Blvd, 2nd Floor, Roswell, GA 30076 Phone: 770-751-2777 Fax: 770-751-2773 |
Dr. Sima Dehghany, MD Family Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1360 Upper Hembree Rd Ste 100, Roswell, GA 30076 Phone: 470-956-4430 |
Dr. Rhett Bergeron, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Sun Valley Dr, Suite D, Roswell, GA 30076 Phone: 678-990-5401 Fax: 678-900-5405 |
Dr. Rina Eisenstein, MD Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 215 Arbor Creek Way, Roswell, GA 30076 Phone: 404-324-7870 |
Onameyore Utuama, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 Hospital Blvd, 1st Floor - Room 110, Roswell, GA 30076 Phone: 770-751-2777 |
Dr. David Alvin Rearick, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 4372 Moss Ridge Ct Ne, Roswell, GA 30075 Phone: 770-992-0059 Fax: 770-992-0912 |
Claudia J Vellozzi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1143 Alpharetta St, Roswell, GA 30075 Phone: 404-616-1550 |
Nailah Abdulbaaqee, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1570 Holcomb Bridge Rd, Roswell, GA 30076 Phone: 404-855-2242 Fax: 404-793-6727 |
Dr. Corazon Cabrera Tan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 880 Holcomb Bridge Rd, Suite 150-b, Roswell, GA 30076 Phone: 770-998-0605 Fax: 770-587-3528 |
David Ludvig Hammer, MD MPH Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10535 Turner Rd, Roswell, GA 30076 Phone: 678-762-1929 |
Dr. Humaira Syed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1143 Alpharetta St, Roswell, GA 30075 Phone: 404-616-1550 |
Lakshmi Gopireddy, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 Hospital Blvd Fl 2, Roswell, GA 30076 Phone: 770-751-2777 Fax: 770-751-2773 |
Dr. Anand Pravin Mehta, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9420 Willeo Rd, Suite 206, Roswell, GA 30075 Phone: 404-439-9851 Fax: 404-994-5765 |
John W Spicer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11205 Alpharetta Hwy Ste H4, Roswell, GA 30076 Phone: 470-645-4686 |
Meredith A Lassiter, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 625 W Crossville Rd Ste 128, Roswell, GA 30075 Phone: 770-587-0101 |
Dr. Heather Donielle Jones, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 801 Macy Dr, Roswell, GA 30076 Phone: 678-799-9277 |
Nandini Sunkireddy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Hospital Blvd Ste 130, Roswell, GA 30076 Phone: 770-740-1753 Fax: 770-740-8503 |
News Archive
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced top-line results from a Phase 2b clinical trial of TC-5619 as an augmentation therapy for the treatment of negative symptoms of schizophrenia.
A new study has found young people are leaving it 'too late' to seek help for eating disorders, citing fear of losing control over their eating or weight, denial, and failure to perceive the severity of the illness as reasons not to get professional advice.
Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sleep-wake regulation currently being studied for the potential treatment of multiple sleep-wake disorders.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 4 days ago